Company / Operating Income per Share
Dexcom Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.37
FY2025
5-year range
$0.77 / $2.77
FY2021-FY2025
Trend
+54.3%
vs FY2024
Sector context
#65 of 154
Health Care
What the data says
At $2.37, Dexcom's operating income per share ranks #65 of 154 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-2.14 in FY2018 to $3.12 in FY2020.
Based on SEC 10-K filings.
2.37 in FY2025 with a 5-year CAGR of -5.3%.
Improved from $1.55 to $2.37 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +45.3%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
#65 of 154 in Health CareTop 42% of 154This company $2.37 Sector average $4.29
▼
-44.7% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 54.3% year-over-year.
- Ranks #65 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.37 | +54.3% |
| FY2024 | $1.54 | -1.0% |
| FY2023 | $1.55 | +100.9% |
| FY2022 | $0.77 | -72.1% |
| FY2021 | $2.77 | -11.3% |
| FY2020 | $3.12 | +100.6% |
| FY2019 | $1.55 | +172.5% |
| FY2018 | -$2.14 | -217.3% |
| FY2017 | -$0.67 | -156.5% |
| FY2016 | -$0.26 | +29.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026